gemcitabine

CARY, N.C. and BRADENTON, Fla., May 20, 2026 Continuity Biosciences has announced the initiation of a Phase I first-in-human...

DALLAS, May 15, 2026 CG Oncology announced positive initial Phase 2 data from the CORE-008 Cohort CX trial, evaluating...